Recipient Age and Mycophenolate Mofetil As the Main Determinants of Outcome after Steroid Withdrawal: Analysis of Long-Term Follow-up in Renal Transplantation
- 27 September 2005
- journal article
- other
- Published by Wolters Kluwer Health in Transplantation
- Vol. 80 (6) , 872-874
Abstract
The long-term benefit of steroid withdrawal on patient and graft survival is unproven. Steroids were stopped within the first year after kidney transplantation in 223 consecutive low-risk patients initially treated with thymoglobulin and triple-drug therapy. The 15-year actuarial graft survival rate was 83.9%. Risk factors for graft loss were: proteinuria (hazard ratio [HR]: 6.96, P = 0.0003), creatinine >130 μmol/L (HR: 3.37, P = 0.01), recipient age P = 0.001), and no mycophenolate mofetil (MMF) treatment (HR: 8.83, P = 0.04). Interestingly, recipient age and no MMF treatment were not risk factors in higher-risk patients in whom steroids were continued. The 2-year incidence of acute rejection following steroid withdrawal was 12.1%; the graft survival rate was lower in this group (71.1%). Our findings indicate that late steroid withdrawal results in excellent long-term outcome in most low-risk patients, but it should be attempted with caution in younger patients and when MMF is not used.Keywords
This publication has 19 references indexed in Scilit:
- Outcome at 3 Years with a Prednisone-Free Maintenance Regimen: A Single-Center Experience with 349 Kidney Transplant RecipientsAmerican Journal of Transplantation, 2004
- Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysisKidney International, 2004
- Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor α Therapy: A Prospective, Randomized, Multicenter StudyAmerican Journal of Transplantation, 2004
- Steroid immunosuppression in kidney transplantation: a passing eraJournal of Surgical Research, 2004
- Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1Transplantation, 2003
- ForewordNephrology Dialysis Transplantation, 2002
- Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter StudyJournal of the American Society of Nephrology, 2002
- DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 2000
- Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppressionThe Lancet, 1996
- EFFECT OF THE MAINTENANCE IMMUNOSUPPRESSIVE DRUG REGIMEN ON KIDNEY TRANSPLANT OUTCOMETransplantation, 1994